1. investors
  2. deal flow
  3. Aeris Biotechnologies

EXPIRED: Aeris Biotechnologies

Aeris Biotechnologies is developing its environmentally friendly, patent protected technology targeting the millions of house dust mites that infest our homes, producing powerful allergens that are linked to asthma and a range of allergies, with hundreds of millions of sufferers worldwide. Aeris has a unique approach to controlling these damaging pests using environmentally friendly biological control. The technology is protected by broad, awarded patents, so that there can be no competitors in protected markets until 2036. Potential sales in patent protected markets alone are projected at over $3 billion a year.

Currently raising funds via Fund My Pitch.

BioTech

Website
Financials
Raising:£4,000,000
Deadline:27-07-2023
Learn More
The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.

If you'd like your events, opportunities and news listed here please join free as an organisation.